Weatherden
↗London, United Kingdom
Weatherden is a global integrated clinical consultancy and drug development firm that bridges the gap between early-stage science and commercial success. The company provides end-to-end expertise in scientific strategy, clinical development, and regulatory pathways, specifically designed to de-risk programs for biopharma startups, venture capital funds, and non-profits.
Weatherden differentiates itself by employing an 'agile biotech mindset' combined with deep pharmaceutical industry experience. Beyond consulting, the firm actively participates in company creation, notably co-founding Elevara Medicines to advance novel therapeutics for chronic inflammatory diseases.
CLASSIFICATION
Company Type:CRO
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Clinical Development Consultancy & CRO
SIZE & FINANCIALS
Employees:1-50
Revenue:$1M-$10M
Founded:2014
Ownership:private
Status:operating
FUNDING
Stage:Unfunded (Self-sustaining consultancy)
Investors:Monograph Capital (Partner in spin-outs)
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 2 (via spin-out Elevara Medicines)
Modalities:Small molecule, Advanced Therapies (ATMP), Cell therapy, Gene therapy, Oral biologics
Active Trials:1
Trial Phases:Phase 1: 1 | Phase 2: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Elevara Medicines (Spin-out)
Key Partnerships:Physiomics (Collaboration on FDA dose optimization guidance), Teijin Pharma (Licensing partner for ELV001), Monograph Capital (Co-founding partner for biotechs)
COMPETITION
Position:Niche Player
Competitors:MCRA, Blue Matter Consulting, S-Cubed, Vasta Global, Boyds
LEADERSHIP
Key Executives:
Emma Tinsley - CEO
Dr. Duncan McHale - Co-Founder
Victoria Simpkin - Chief Business Officer
Scientific Founders:Professor Houman Ashrafian, Dr. Duncan McHale
Board Members:Professor Houman Ashrafian (Chairman - currently Head of R&D at Sanofi)
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Weatherden. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.